Opinion

Video

Social and Cultural Stigma of Psoriasis in Patients With Skin of Color

Drs Stein Gold, Shahriari and Desai highlight social and cultural stigma of psoriasis in patients with skin of color and its impact on patient’s quality of life.

This is a video synopsis/summary of a panel discussion involving Linda Stein Gold, MD; Mona Shahriari, MD, FAAD; and Seemal Desai, MD.

In this conversation on the impact of psoriasis in patients with skin of color, the participants highlight the significant burden the disease carries, particularly from a quality of life perspective. They note the cultural stigma associated with skin conditions, which can lead to isolation and emotional distress for affected individuals.

The speakers emphasize the importance of understanding the unique challenges faced by patients with skin of color, including the psychological impact of post-inflammatory changes and dyspigmentation. They advocate for a compassionate approach and early consideration of systemic medications to prevent long-term pigmentary sequelae.

They discuss the cultural significance of visible skin conditions, such as psoriasis on the hands or face, within certain communities. He stresses the role of dermatologists in addressing not only the physical symptoms but also the social and cultural implications of the disease.

The conversation underscores the need for culturally competent care and emphasizes the importance of listening to patients' experiences and concerns. By acknowledging and addressing the impact of psoriasis on both physical and emotional well-being, healthcare providers can better support patients in managing their condition and improving their overall quality of life.

Video synopsis is AI-generated and reviewed by HCPLive editorial staff.

Related Videos
Implications of Findings on Patient-Reported Outcomes for Roflumilast Foam, with Melinda Gooderham, MD
New Findings on Psoriasis Outcomes for Roflumilast Foam 0.3%, with Melinda Gooderham, MD
Methods to Manage Psoriasis Using Oral Therapies, with Andrea Murina, MD
James Del Rosso, DO: Discussing What’s New in the Medicine Chest for Dermatologists
Melodie Young, ASN, RN: Updates on Therapies for Pediatric Patients with Psoriasis, PsA
Harnessing Patient Insights: The Role of PROs in Managing Psoriasis and Psoriatic Arthritis
Melinda Gooderham, MD: What Do the New Roflumilast Foam Data Mean for Psoriasis Patients?
Linda Stein Gold, MD, and Bruce Strober, MD, PhD
Linda Stein Gold, MD, and Bruce Strober, MD, PhD
Linda Stein Gold, MD, and Bruce Strober, MD, PhD
© 2024 MJH Life Sciences

All rights reserved.